After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends

  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 51%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

CNBC’s Jim Cramer on Thursday recommended that investors not base portfolio decisions solely off of macro economic trends.

CNBC's Jim Cramer on Thursday recommended that investors not base portfolio decisions solely off of macro economic trends, like new employment data or interest rates.

He discussed pharmaceutical giant Eli Lilly's blow-out quarter, saying its success is not due to general attitudes on the market.on Thursday recommended that investors not base portfolio decisions solely off macroeconomic trends, like new employment data or interest rates."I don't want to be bound by the four walls of the PMIs, the PPIs, the PCDEs, the GDPs.

was not due to mortgage rates or other macro factors. He said the quarter shows that Eli Lilly is ahead of its competitors when it comes to drug formulations and the ability to scale manufacturing. Cramer reiterated his long-held belief that it's prudent to invest in good companies and hold onto their shares as long as business seems solid.

"If you pay attention to the real world, you may find yourself taking a GLP-1 and want to buy the stock of Eli Lilly," he said."But if you pay too much attention to the financial world, you might've convinced yourself that this stock wasn't worth owning."Sign up for our free Olympics Headlines newsletter.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 545. in CA

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Amazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbookAmazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbook
Source: Investingcom - 🏆 450. / 53 Read more »